Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹2804 Cr.
Stock P/E
60
P/B
12.4
Current Price
₹171.9
Book Value
₹ 13.9
Face Value
1
52W High
₹178.6
52W Low
₹ 65
Dividend Yield
0%

KMC Speciality Hosp. Overview

Business

KMC Speciality Hospitals (India) Ltd. operates as a healthcare provider in India, primarily focusing on specialty hospital services. The company offers a range of medical services including in-patient and out-patient care, diagnostic services, emergency services, and various surgical procedures across multiple medical disciplines. Its core business model revolves around providing comprehensive, high-quality healthcare to patients through its hospital facilities. The company generates revenue through fees charged for consultations, medical procedures, surgeries, room charges, diagnostic tests, and pharmacy sales.

Revenue Mix

While specific revenue percentages are not provided, typical revenue segments for a multi-speciality hospital like KMC would include:

In-patient services: This usually constitutes the largest portion of revenue, including room charges, surgical fees, treatment costs, and intensive care.

Out-patient services: Consultations, minor procedures, and follow-up visits.

Diagnostic services: Lab tests, radiology, imaging scans.

Pharmacy sales: Revenue from medicines dispensed within the hospital.

Other services: Emergency care, health check-ups, etc.

Industry

The Indian hospital and healthcare services industry is large and growing, characterized by increasing demand for quality healthcare. It is highly fragmented, with a mix of large corporate hospital chains, regional players, single-site hospitals, and public sector hospitals. KMC Speciality Hospitals likely positions itself as a provider of specialized medical care, competing on the basis of medical expertise, technology, and patient outcomes within its operating regions. It would face competition from both larger national chains with deeper pockets and local standalone hospitals.

MOAT

Brand & Reputation: A strong local or regional brand built on clinical excellence and patient trust in specific specialties can create a durable advantage.

Doctor Relationships: Long-standing relationships with leading doctors and specialists, who often attract patient flow.

Specialized Expertise/Technology: Investment in advanced medical technology and highly specialized departments (e.g., oncology, cardiology, neurosurgery) can differentiate it.

Local Network Effects: Established presence and referral networks within its operating geographies.

Switching Costs: While not always high, for critical or ongoing specialty treatments, patients face high implicit switching costs.

Growth Drivers

Rising Healthcare Demand: Driven by a growing and aging population, increasing prevalence of chronic diseases, and higher health awareness.

Increasing Health Insurance Penetration: Expanding coverage by both government and private insurance schemes makes healthcare more accessible and affordable.

Higher Disposable Incomes: Leading to increased willingness and ability to spend on quality private healthcare.

Medical Tourism: India's potential as a medical tourism destination for certain high-end procedures attracts international patients.

Technological Advancement: Adoption of new medical technologies and procedures allows for expansion of services and improved outcomes.

Expansion & Capacity Addition: Organic growth through increasing bed capacity, adding new specialties, or inorganic growth through acquisitions.

Risks

Regulatory & Pricing Pressure: Government interventions like price caps on medical procedures, drugs, or medical devices can impact profitability.

Talent Attrition: Shortage and high attrition rates of skilled medical professionals (doctors, nurses, technicians) leading to higher salary costs.

Intense Competition: Fierce competition from other private players, including large hospital chains expanding their footprint, leading to pricing pressures and challenges in patient acquisition.

Capital Expenditure: Hospitals are highly capital-intensive businesses requiring significant investment in infrastructure, equipment, and technology.

Medical Malpractice & Litigation: Risks associated with medical errors and subsequent legal liabilities.

Economic Downturns: Reduced discretionary spending on healthcare during economic slowdowns, impacting elective procedures.

Management & Ownership

As a publicly listed company, KMC Speciality Hospitals (India) Ltd. would have a mix of promoter shareholding, institutional investors, and public shareholders. In India, many hospital chains originate from entrepreneurial or physician-led initiatives, which often translates into a promoter-driven management culture focused on operational execution and clinical outcomes. The management would be responsible for strategic growth, operational efficiency, regulatory compliance, and maintaining clinical standards.

Outlook

The Indian healthcare sector is poised for substantial long-term growth driven by fundamental demographic tailwinds, rising incomes, and increasing health insurance coverage. KMC Speciality Hospitals, as a player in this sector, is well-positioned to benefit from these trends, especially given its focus on specialized care which often commands higher margins. However, the company faces inherent challenges including intense competition, the need for continuous capital investment in technology and infrastructure, and potential regulatory interventions on pricing. Success will depend on its ability to effectively manage costs, attract and retain top medical talent, maintain a strong clinical reputation, and strategically expand its service offerings and geographical footprint while navigating the dynamic regulatory landscape.

KMC Speciality Hosp. Share Price

Live · BSE / NSE · Inception: 1982
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

KMC Speciality Hosp. Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 45 53 56 61 61 67 75 82 82 92
Other Income 1 1 0 1 1 1 1 1 2 2
Total Income 46 54 57 63 62 67 76 83 84 94
Total Expenditure 33 40 44 45 46 50 54 57 56 63
Operating Profit 13 14 13 17 16 17 22 26 28 30
Interest 0 2 3 2 2 2 2 2 2 2
Depreciation 3 4 5 5 5 5 5 5 6 6
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 9 7 5 10 9 10 15 18 20 22
Provision for Tax 2 2 1 3 4 2 4 5 5 6
Profit After Tax 7 6 4 8 5 8 11 14 15 17
Adjustments -0 0 -0 0 0 0 -0 -0 0 0
Profit After Adjustments 7 6 4 8 5 8 11 14 15 17
Adjusted Earnings Per Share 0.4 0.3 0.2 0.5 0.3 0.5 0.7 0.8 0.9 1

KMC Speciality Hosp. Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 43 55 71 82 96 103 136 156 177 232 306 331
Other Income 1 0 0 2 1 3 2 3 4 3 5 6
Total Income 44 55 71 84 98 105 138 159 181 235 311 337
Total Expenditure 35 42 56 66 75 80 99 114 130 174 218 230
Operating Profit 9 13 15 18 23 25 40 45 51 61 94 106
Interest 2 1 1 1 1 1 1 1 2 10 9 8
Depreciation 3 3 4 4 5 6 7 8 9 19 22 22
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 4 8 10 12 17 18 32 36 41 32 63 75
Provision for Tax 1 3 3 4 5 5 8 9 10 10 16 20
Profit After Tax 3 5 7 9 12 13 24 27 30 21 47 57
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 3 5 7 9 12 13 24 27 30 21 47 57
Adjusted Earnings Per Share 0.2 0.3 0.4 0.5 0.7 0.8 1.5 1.6 1.9 1.3 2.9 3.4

KMC Speciality Hosp. Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 13 24 30 39 51 63 87 114 144 164 210
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 6 3 10 8 6 26 20 40 64 72 61
Other Non-Current Liabilities 0 -5 -4 -3 11 18 26 38 51 60 82
Total Current Liabilities 10 10 12 12 12 13 20 23 46 38 43
Total Liabilities 29 33 49 56 80 120 152 214 305 335 397
Fixed Assets 23 24 36 36 39 74 75 84 205 247 247
Other Non-Current Assets 4 4 4 8 23 20 34 78 66 54 68
Total Current Assets 3 4 8 13 18 26 42 52 34 33 81
Total Assets 29 33 49 56 80 120 152 214 305 335 397

KMC Speciality Hosp. Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 0 0 1 0 2 1 2 2 2 5 9
Cash Flow from Operating Activities 6 10 12 16 11 26 29 32 38 58 79
Cash Flow from Investing Activities -1 -4 -19 -9 -8 -43 -29 -48 -56 -51 -17
Cash Flow from Financing Activities -5 -5 6 -5 -4 18 -1 16 20 -2 -21
Net Cash Inflow / Outflow -0 1 -1 1 -1 1 -0 0 3 4 41
Closing Cash & Cash Equivalent 0 1 0 2 1 2 2 2 5 9 50

KMC Speciality Hosp. Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 0.2 0.33 0.41 0.53 0.72 0.78 1.45 1.64 1.86 1.31 2.87
CEPS(Rs) 0.4 0.52 0.64 0.79 1.02 1.16 1.86 2.11 2.43 2.48 4.19
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0.82 1.47 1.86 2.4 3.11 3.88 5.32 6.96 8.8 10.08 12.9
Core EBITDA Margin(%) 18.89 22.76 20.27 19.8 22.21 22.25 27.38 26.51 26.63 24.76 28.85
EBIT Margin(%) 13.38 17.15 15.26 16.69 18.54 18.73 24.31 23.83 23.78 17.97 23.52
Pre Tax Margin(%) 9.53 14.57 13.87 14.99 17.36 17.58 23.59 23.11 22.89 13.65 20.61
PAT Margin (%) 7.55 9.77 9.41 10.46 12.21 12.45 17.44 17.13 17.15 9.25 15.28
Cash Profit Margin (%) 15.26 15.59 14.88 15.57 17.35 18.46 22.23 22.04 22.35 17.44 22.37
ROA(%) 10.63 17.14 16.3 16.4 17.24 12.81 17.48 14.59 11.7 6.7 12.78
ROE(%) 27.24 28.6 24.43 24.78 26.17 22.42 31.61 26.65 23.63 13.92 24.94
ROCE(%) 23.92 34.73 28.63 29.11 33.09 25.85 32.44 27.32 22.54 18.01 27.25
Receivable days 11.65 10.83 10.74 9.23 7.27 8.28 8.17 9.27 9.02 8.16 7.96
Inventory Days 5.79 4.33 3.49 3.58 5.99 7.07 4.86 4.86 4.45 4.37 4.41
Payable days 155.97 129.77 128.17 143.12 127.26 106.85 94.22 93.91 87.87 105.29 98.13
PER(x) 39.98 39.63 44.01 29.22 17.39 27.82 38.25 35.16 43.57 46.73 27.48
Price/Book(x) 9.59 8.83 9.63 6.44 4.03 5.61 10.46 8.27 9.22 6.09 6.1
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 3.25 3.97 4.3 3.1 2.1 3.55 6.62 6.06 7.75 4.64 4.25
EV/Core EBITDA(x) 15.43 17.28 20.74 14.25 8.87 14.37 22.76 21.09 26.74 17.73 13.9
Net Sales Growth(%) 17.27 28.81 28.89 16.4 16.92 6.71 32.58 14.47 13.75 30.72 32.03
EBIT Growth(%) 165.58 65.12 14.64 27.36 29.88 7.79 72.1 12.21 13.53 -1.23 72.78
PAT Growth(%) 2493.79 66.61 24.24 29.4 36.42 8.83 85.66 12.49 13.83 -29.47 118.11
EPS Growth(%) 2493.42 66.57 24.25 29.39 36.42 8.83 85.66 12.49 13.83 -29.47 118.1
Debt/Equity(x) 0.77 0.26 0.48 0.26 0.15 0.43 0.31 0.39 0.5 0.5 0.34
Current Ratio(x) 0.31 0.41 0.68 1.01 1.43 2.08 2.18 2.3 0.72 0.88 1.9
Quick Ratio(x) 0.24 0.35 0.63 0.94 1.25 1.94 2.08 2.2 0.68 0.78 1.81
Interest Cover(x) 3.47 6.64 11.01 9.8 15.67 16.33 33.73 32.93 26.65 4.16 8.09
Total Debt/Mcap(x) 0.08 0.03 0.05 0.04 0.04 0.08 0.03 0.05 0.05 0.08 0.06

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +32% +25% +24% +22%
Operating Profit CAGR +54% +28% +30% +26%
PAT CAGR +124% +20% +29% +32%
Share Price CAGR +160% +24% +19% +31%
ROE Average +25% +21% +24% +25%
ROCE Average +27% +23% +26% +28%

KMC Speciality Hosp. Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 75 %
FII 0.02 %
DII (MF + Insurance) 0 %
Public (retail) 24.98 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 75757575757575757575
FII 00000.0100000.02
DII 0000000000
Public 2525252524.992525252524.98
Others 0000000000
Total 100100100100100100100100100100

KMC Speciality Hosp. Peer Comparison

Hospital & Healthcare Services Edit Columns

KMC Speciality Hosp. Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

KMC Speciality Hosp. Pros & Cons

Pros

  • Company has delivered good profit growth of 29% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 21%
  • Debtor days have improved from 105.29 to 98.13days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 12.4 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp